Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Dow Jones Surges 600 Points As Goldman, J&J Report Earnings; Netflix Earnings Due

The Dow Jones Industrial Average surged Tuesday, as Goldman Sachs and J&J reported earnings results. Netflix earnings are due out late.

Investors Business Daily

Dow Jones Surges 550 Points, But This Key Signal Missing; Netflix, Tesla Earnings On Deck

Dow Jones futures were higher ahead of Tuesday's open after the Dow Jones Industrial Average surged more than 550 points Monday.

Investors Business Daily

Dow Jones Surges 600 Points As Bank Of America Jumps On Earnings; Apple Called Top Pick

The Dow Jones Industrial Average rallied Monday, as Bank of America jumped on strong earnings results. Apple stock was named a top pick.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Breakthrough cancer vaccine could be ready in months, say scientists

Manufacturers Moderna and Merck are testing a breakthrough cancer vaccine for patients suffering from melanoma which kills thousands of people each year in the UK

Daily Mirror

Dow Jones Reverses As JPMorgan, UnitedHealth Rally On Earnings; Retail Sales Miss

The Dow Jones Industrial Average reversed lower Friday on hot inflation data. JPMorgan and UnitedHealth rallied on earnings results.

Investors Business Daily

Dow Jones Dives 500 Points On Hot Inflation Report; 10-Year Treasury Yield Tops 4%; Apple, Tesla Drop

The Dow Jones Industrial Average dived Thursday on hot inflation data from the consumer price index. The 10-year Treasury yield topped 4%.

Investors Business Daily

Dow Jones Closes Lower After Fed Minutes Point To 4.6% Terminal Rate; Solar Stocks Fall; Microsoft's $69 Bil Battle Continues

The small-cap Russell 2000 pared losses after it led declines by nearly 1% in the morning session.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Stock Market Inching Higher; Fed Minutes On Tap; Education Stock Breaks Out

The stock market flashed a mild shade of green at noon on Wednesday. Investors now await the 2pm Fed Minutes.

Investors Business Daily

Moderna Surges As Merck Inks Deal To Co-Develop Personalized Cancer Vaccine Treatment

Merck opted Wednesday to help Moderna develop a personalized cancer vaccine based on messenger RNA technology, and MRNA stock rocketed.

Investors Business Daily

Moderna Stock Surges On Cancer Vaccine Development Pact With Merck

"Together we have made significant progress in advancing mRNA-4157 as an investigational personalized cancer treatment used in combination with (Merck & Co.'s) Keytruda," Moderna said Wednesday.

The Street

Dow Jones Reverses On Hot Inflation Data; Fed Minutes Up Next; PepsiCo Jumps On Earnings

The Dow Jones Industrial Average fell Wednesday on hot inflation data. Minutes from Federal Reserve's policy meeting are due out today.

Investors Business Daily

IBD 50 Stocks To Watch: Dow Jones Leader Merck Approaches Buy Point

Dow Jones leader Merck is one of the top stocks to watch, as it approaches a new buy point despite the stock market correction.

Investors Business Daily

Merck Scores A 'Must-Win' For Its $11.5 Billion Acceleron Buyout

Merck stock jumped Monday after a drug it acquired for billions scored a "must-win" in patients with a rare blood pressure condition.

Investors Business Daily

Amazon Halts Delivery Bots; Merck's Covid-19 Pill Didn't Reduce Risk; Samsung Profits Slip; Adidas Reviews Relationship With Kanye: Top Stories Friday, Oct. 7

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Falls As Recession Fears Rise; Elon Musk Lashes Out Over This Recall; Bitcoin Rallies, Coinbase Falls

The Dow Jones fell amid recession fears after the latest Fed meeting. Tesla stock fell and Elon Musk lashed out after a mass recall. Bitcoin rallied.

Investors Business Daily

Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs

Merck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris over an ingredient used in diabetes meds.

Investors Business Daily

Dow Jones Rises Ahead Of Fed Decision, Powell Comments

The Dow Jones Industrial Average rose Wednesday ahead of the Federal Reserve's interest rate decision and Fed chief Powell's press conference.

StockNews.com

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Sells Off Ahead Of Fed Meeting; Treasury Yields Jump; Ford Dives 10% On Inflation Warning

The Dow Jones Industrial Average sold off 350 points Tuesday ahead of the Federal Reserve's two-day policy meeting.

Investors Business Daily

Dow Jones Futures: Fed Meeting Looms; What To Do In New Stock Market Correction

Dow Jones futures dropped after Monday's stock market rally ahead of the Federal Reserve's two-day policy meeting.

Investors Business Daily

Dow Jones Falls As 10-Year Treasury Yield Surges Ahead Of Fed Meeting

The Dow Jones Industrial Average fell Monday, as the 10-year Treasury yield surged to hit an 11-year high ahead of the Fed meeting.

Investors Business Daily

Fund Tops Market With Higher Income, Low Volatility Strategy

Are you spooked because the S&P 500 is off 16.26% going into Thursday? If you are, then check out Hartford Equity Income Fund. It's beating the bogey.

StockNews.com

2 Reliable Drug Stocks to Buy and Hold for Big-Time Gains

Persistent rate hikes by the Fed and rising odds of a recession have aggravated market turbulence and led investors to seek refuge in defensive sectors such as healthcare. Defensive stocks tend to perform well in declining markets due to the steady demand for their products. Hence, consistent dividend-yielding drug stocks…

Benzinga

Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary

Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), the study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Akero Therapeutics shares…

Investors Business Daily

Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today

A gamble could pay off for Merck stock after blockbuster Keytruda nearly doubled the five-year survival rate for some lung cancer patients.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.